SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)
$0 None (None%)
Analysed SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) News Sources
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
06-12-2025
yahoo.com
Shanghai Junshi Biosciences (SEHK:1877): Revisiting Valuation After a Volatile Share Price Rebound
08-12-2025
yahoo.com
Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)
25-02-2026
yahoo.com
Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)
25-02-2026
yahoo.com
Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications
09-03-2026
yahoo.com
Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates
13-03-2026
yahoo.com
Shanghai Junshi Biosciences (SEHK:1877) Valuation Check After Mixed One Year And Three Year Returns
25-03-2026
yahoo.com
Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026
20-04-2026
yahoo.com
Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma
21-05-2026
yahoo.com
Junshi Biosciences Announces Primary Endpoints Met in Final Analysis of Phase 3 Study for Perioperative Toripalimab plus Chemotherapy for Resectable Stage II-III NSCLC
27-05-2026
yahoo.com
What is the current price of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)?
The current price of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) is $0.
SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) since the previous trading day is $None.
SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)?
The most recent average sentiment score for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) is 60 out of 100.
What is the most recent average sentiment for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)?
The most recent sentiment for SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS) is .
SEC-8K** Filing Available For SHANGHAI JUNSHI BIOSCIENCE-H (SHJBF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.